Financials
- Market Capitalization 8.4 B
- Employee 399
- Founded 1993
- CEO Michael S Weiss
- Website www.tgtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000FVZQY1
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
10.76
市销率
7.81
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 999 | SYRE Spyre Therapeutics, Inc. - Common Stock | 98.95 USD | +5.57% | +4.89% | +18.45% | +313.84% | 8.59 B USD | ||
| 1006 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 131.27 USD | +1.06% | -5.90% | +16.34% | +74.72% | 8.44 B USD | ||
| 1017 | APGE Apogee Therapeutics, Inc. - Common Stock | 133.96 USD | +0.10% | +0.33% | +55.42% | +149.97% | 8.29 B USD | ||
| 1022 | IBRX ImmunityBio, Inc. - Common Stock | 7.88 USD | +1.16% | -9.43% | +10.67% | +184.48% | 8.25 B USD |